A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
Clinical trial NCT04275583 · UNKNOWN
Trial details
- NCT number
- NCT04275583
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-28
- Primary completion
- 2022-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.